Maximize merger arbitrage growth returns
Out maneuver the market and identify potential regulatory hurdles for mergers and acquisitions with MLex. Our exclusive market insight, analysis and commentary covers deals from pre-notification through notification, review and approval.
The world's leading hedge funds use the MLex DealRisk service to analyze deals through notification, review, approval and compliance with daily case updates on M&A clearance.
As reported first by MLex
Like to read the full text of these, or any other MLex insights? Request a trial subscription via the form at the bottom of the page.
Bayer-Monsanto deal hasn't received staff recommendation at US DOJ; decision expected by early April
2 March 18
Qualcomm still to refile NXP deal to China’s Mofcom as deadline looms
12 April 2018
Tronox, Cristal point to Chinese competition in EU hearing on titanium-dioxide deal
11 April 2018
Our coverage includes exclusive insight and analysis on the following key deals around the globe.
Meet our global experts
Below is a small selection of our Mergers & Acquisitions editorial experts. See our complete contributor list for more.
Request a Free Trial
We may contact you with details of other LexisNexis products, services and events we believe you may be interested in as a result of your relationship with us. You can amend your communication preferences via our MLex Preference Center.
Looking for breaking news and to review regulatory implications for specific deals? Complete the form to request a free, limited trial to MLex.